ArticleBone reports2021

Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.

Tomonori Kobayakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.